C. A. Bonilla, A. Crossa, H. O. Jave, C. D. Mitnick, R. B. Jamanca, C. Herrera, L. Asencios, A. Mendoza, J. Bayona, and M. Zignol, "Management of extensively drug-resistant tuberculosis in Peru: Cure is possible," PLoS One, vol. 3, 2008.
 World Health Organization (WHO), "Management of MDR-TB: A ﬁeld guide: A companion document to guidelines for programmatic management of drug-resistant tuberculosis: Integrated management of adolescent and adult illness," (IMAI). WHO/HTM/TB/2008, 2008.
 N. S. Shah, A. Wright, G.-H. Bai, L. Barrera, F. Boulahbal, N. Martín-Casabona, F. Drobniewski, C. Gilpin, M. Havelková, and R. Lepe, "Worldwide emergence of extensively drug-resistant tuberculosis," Emerging Infectious Diseases, vol. 13, pp. 380-387, 2007.
 World Health Organization (WHO), "Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response," Report No. WHO/HTM/TB/2010.3. Geneva: The Organization2010.
 A. Matteelli, G. B. Migliori, D. Cirillo, R. Centis, E. Girard, and M. Raviglione, "Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: Epidemiology and control," Expert Review of Anti-Infective Therapy, vol. 5, pp. 857-871, 2007.
 G. B. Migliori, G. Besozzi, E. Girardi, K. Kliiman, C. Lange, O. Toungoussova, G. Ferrara, D. Cirillo, A. Gori, and A. Matteelli, "Clinical and operational value of the extensively drug-resistant tuberculosis definition," European Respiratory Journal, vol. 30, pp. 623-626, 2007. Available at: https://doi.org/10.1183/09031936.00077307.
 H. S. Cox, C. Sibilia, S. Feuerriegel, S. Kalon, J. Polonsky, A. K. Khamraev, S. Rüsch-Gerdes, C. Mills, and S. Niemann, "Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis," New England Journal of Medicine, vol. 359, pp. 2398-2400, 2008. Available at: https://doi.org/10.1056/nejmc0805644.
 A. D. Calver, M. Murray, O. J. Strauss, E. M. Streicher, M. Hanekom, T. Liversage, M. Masibi, P. D. Van Helden, R. M. Warren, and T. C. Victor, "Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa," Emerging Infectious Diseases, vol. 16, p. 264, 2010. Available at: https://doi.org/10.3201/eid1602.090968.
 N. R. Gandhi, A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland, "Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa," The Lancet, vol. 368, pp. 1575-1580, 2006. Available at: https://doi.org/10.1016/s0140-6736(06)69573-1.
 C. D. Mitnick, S. S. Shin, K. J. Seung, M. L. Rich, S. S. Atwood, J. J. Furin, G. M. Fitzmaurice, V. F. A. Alcantara, S. C. Appleton, J. N. Bayona, C. A. Bonilla, S. K. Chalco, M. F. Choi, H. S. Franke, D. Fraser, R. M. Guerra, D. Hurtado, K. Jazayeri, K. Joseph, L. Llaro, J. S. Mestanza, M. Mukherjee, E. Muñoz, E. Palacios, A. Sanchez, Sloutsky, and M. C. Becerra, "Comprehensive treatment of extensively drug-resistant tuberculosis," The New England Journal of Medicine, vol. 359, pp. 563–74, 2008.
 S. D. Lawn, P. Mwaba, M. Bates, A. Piatek, H. Alexander, B. J. Marais, L. E. Cuevas, T. D. McHugh, L. Zijenah, and N. Kapata, "Advances in tuberculosis diagnostics: The Xpert MTB/RIF assay and future prospects for a point-of-care test," The Lancet Infectious Diseases, vol. 13, pp. 349-361, 2013. Available at: https://doi.org/10.1016/s1473-3099(13)70008-2.
 R. M. Green and S. Flamm, "AGA technical review on the evaluation of liver chemistry tests," Gastroenterology, vol. 123, pp. 1367-1384, 2002. Available at: https://doi.org/10.1053/gast.2002.36061.
 C. Benichou, "Criteria of drug-induced liver disorders. Report of an international consensus meeting," Journal of Hepatology, vol. 11, pp. 272-276, 1990. Available at: https://doi.org/10.1016/0168-8278(90)90124-a.
 D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff, "Diagnosis and monitoring of hepatic injury: I. Performance characteristics of laboratory tests," Clinical Chemistry, vol. 46, pp. 2027–2049, 2000a.
 D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff, "Diagnosis and monitoring of hepatic injury: II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring," Clinical Chemistry, vol. 46, pp. 2050–2068, 2000b.
 D. Larrey, "Epidemiology and individual susceptibility to adverse drug reactions affecting the liver," Seminars in Liver Disease, vol. 22, pp. 145–156, 2002. Available at: https://doi.org/10.1055/s-2002-30101.
 G. M. Williams and M. J. Iatropoulos, "Alteration of liver cell function and proliferation: Differentiation between adaptation and toxicity," Toxicologic Pathology, vol. 30, pp. 41-53, 2002. Available at: https://doi.org/10.1080/01926230252824699.
 A. K. Tetteh, E. Agyarko, J. Otchere, L. Bimi, and I. Ayi, "An evaluation of treatment outcomes in a cohort of clients on the DOTS strategy, 2012-2016," Tuberculosis Research and Treatment, p. 7, 2018.
 World Health Organization (WHO), Improving the diagnosis and treatment of smear negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: Recommendation for HIV-prevalent and resource-constrained setting. Geneva: WHO, 2007.